VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 176 filers reported holding VANDA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 1.47 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $79 | -100.0% | 10,740 | -83.8% | 0.00% | -89.5% |
| Q2 2022 | $721,000 | -35.2% | 66,114 | -32.8% | 0.02% | -26.9% |
| Q1 2022 | $1,112,000 | +5.0% | 98,356 | +45.7% | 0.03% | +44.4% |
| Q4 2021 | $1,059,000 | +246.1% | 67,510 | +278.2% | 0.02% | +260.0% |
| Q3 2021 | $306,000 | -59.8% | 17,850 | -49.6% | 0.01% | -64.3% |
| Q2 2021 | $762,000 | -8.2% | 35,420 | -35.9% | 0.01% | -17.6% |
| Q1 2021 | $830,000 | +204.0% | 55,253 | +166.2% | 0.02% | +112.5% |
| Q4 2020 | $273,000 | -13.9% | 20,755 | -36.7% | 0.01% | -42.9% |
| Q3 2020 | $317,000 | +6.7% | 32,779 | +26.1% | 0.01% | -6.7% |
| Q2 2020 | $297,000 | -73.9% | 25,999 | -76.3% | 0.02% | -85.3% |
| Q1 2020 | $1,136,000 | -22.0% | 109,610 | +23.4% | 0.10% | +56.9% |
| Q4 2019 | $1,457,000 | -17.8% | 88,798 | -33.4% | 0.06% | +6.6% |
| Q3 2019 | $1,772,000 | -5.4% | 133,417 | +0.4% | 0.06% | +15.1% |
| Q2 2019 | $1,873,000 | +5.9% | 132,941 | +38.4% | 0.05% | -27.4% |
| Q1 2019 | $1,768,000 | +15.2% | 96,080 | +63.6% | 0.07% | +143.3% |
| Q4 2018 | $1,535,000 | +166.0% | 58,732 | +133.7% | 0.03% | +100.0% |
| Q3 2018 | $577,000 | -66.6% | 25,127 | -72.3% | 0.02% | -75.0% |
| Q2 2018 | $1,728,000 | +45.7% | 90,691 | +28.8% | 0.06% | +57.9% |
| Q1 2018 | $1,186,000 | +307.6% | 70,386 | +267.1% | 0.04% | +442.9% |
| Q4 2017 | $291,000 | +11.5% | 19,172 | +31.4% | 0.01% | 0.0% |
| Q3 2017 | $261,000 | -46.3% | 14,590 | -51.1% | 0.01% | -53.3% |
| Q2 2017 | $486,000 | -20.5% | 29,811 | -31.7% | 0.02% | -21.1% |
| Q1 2017 | $611,000 | -24.2% | 43,658 | -13.6% | 0.02% | -9.5% |
| Q4 2016 | $806,000 | -1.1% | 50,547 | +3.3% | 0.02% | +10.5% |
| Q3 2016 | $815,000 | +473.9% | 48,953 | +284.9% | 0.02% | +533.3% |
| Q2 2016 | $142,000 | -64.7% | 12,719 | -70.6% | 0.00% | -72.7% |
| Q4 2015 | $402,000 | -12.6% | 43,204 | +6.0% | 0.01% | -31.2% |
| Q3 2015 | $460,000 | +71.0% | 40,776 | +92.4% | 0.02% | +100.0% |
| Q2 2015 | $269,000 | +15.9% | 21,194 | -15.2% | 0.01% | +14.3% |
| Q1 2015 | $232,000 | – | 25,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 4,658,759 | $121,733,000 | 8.95% |
| Palo Alto Investors LP | 4,155,670 | $108,588,000 | 5.78% |
| Stonepine Capital Management, LLC | 220,848 | $5,771,000 | 5.07% |
| Birchview Capital, LP | 80,000 | $2,090,000 | 1.98% |
| EAM Global Investors LLC | 75,310 | $1,968,000 | 1.08% |
| Atika Capital Management LLC | 130,000 | $3,397,000 | 1.00% |
| EAM Investors, LLC | 110,806 | $2,895,000 | 0.79% |
| UNIVERSITY OF NOTRE DAME DU LAC | 97,521 | $2,548,000 | 0.62% |
| ALGERT GLOBAL LLC | 76,204 | $1,991,000 | 0.56% |
| 361 CAPITAL LLC | 85,885 | $2,244,000 | 0.46% |